The most reported side effects include: Mild to moderate nausea, particularly in the first few weeks Digestive discomfort (bloating, constipation, or loose stools) Occasional fatigue during dose escalation periods The important context: These effects are typically temporary and resolve as your body adapts Proper dose titration significantly reduces severity Serious adverse events are rare and were closely monitored in clinical trials Conditions that may make tirzepatide inappropriate include certain thyroid disorders, specific endocrine conditions, and other contraindications identified during a medical evaluation
Exceeding recommended doses (typically above 1,000 mg/day) increases the likelihood of digestive side effects such as bloating, cramping, and loose stools
Your healthcare provider can track these improvements over time
People with severe or treatment-resistant depression, or whose bouts of depression began earlier in life, have particularly low blood levels of the substance
Given their clinical benefits and high price tags, GLP-1 RAs exemplify a tension in drug coverage: broad therapeutic value versus cost-containment